These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8746659)

  • 21. Clinical pharmacology of gatifloxacin, a new fluoroquinolone.
    Grasela DM
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S51-8. PubMed ID: 10984329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug interactions with antacids. Mechanisms and clinical significance.
    Sadowski DC
    Drug Saf; 1994 Dec; 11(6):395-407. PubMed ID: 7727050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug metabolism and drug interaction of anxiolytics].
    Uchimura N; Etou Y
    Ryoikibetsu Shokogun Shirizu; 2003; (38):612-6. PubMed ID: 12877062
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of transporter-mediated drug absorption, distribution, elimination and drug interactions in antimicrobial chemotherapy.
    Tsuji A
    J Infect Chemother; 2006 Oct; 12(5):241-50. PubMed ID: 17109086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic interaction of fluoroquinolones and other drugs].
    Iakovlev VP
    Antibiot Khimioter; 1998; 43(7):36-44. PubMed ID: 9727166
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug interaction with quinolone antibiotics in intensive care unit patients.
    Willams TW; Yuk JH
    Arch Intern Med; 1991 Dec; 151(12):2485. PubMed ID: 1747011
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacokinetic properties of ofloxacin (review of the literature].
    Iakovlev VP
    Antibiot Khimioter; 1996; 41(9):24-32. PubMed ID: 9005781
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetic drug-drug interactions between calcineurin inhibitors and proliferation signal inhibitors with anti-microbial agents: implications for therapeutic drug monitoring.
    Page RL; Mueller SW; Levi ME; Lindenfeld J
    J Heart Lung Transplant; 2011 Feb; 30(2):124-35. PubMed ID: 21115368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciprofloxacin and antacids.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Lancet; 1986 Jul; 2(8497):48. PubMed ID: 2873348
    [No Abstract]   [Full Text] [Related]  

  • 30. [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
    Padeĭskaia EN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(2):30-9. PubMed ID: 9551171
    [No Abstract]   [Full Text] [Related]  

  • 31. Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies.
    Moss DM; Marzolini C; Rajoli RK; Siccardi M
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1203-17. PubMed ID: 25872900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common antacids could help keep gingivitis at bay.
    Br Dent J; 2006 Nov; 201(10):620. PubMed ID: 17128225
    [No Abstract]   [Full Text] [Related]  

  • 33. [Moxifloxacin--antimicrobial activity and pharmacokinetic properties].
    Iakovlev VP; Polushkina NR
    Antibiot Khimioter; 2002; 47(5):19-29. PubMed ID: 12365324
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics and safety assessment of tosufloxacin tosilate.
    Niki Y
    J Infect Chemother; 2002 Mar; 8(1):1-18. PubMed ID: 11957114
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinically desirable drug interactions.
    Caranasos GJ; Stewart RB; Cluff LE
    Annu Rev Pharmacol Toxicol; 1985; 25():67-95. PubMed ID: 3890713
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):46-52. PubMed ID: 9825111
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetic Drug-Drug Interactions Between Immunosuppressant and Anti-Infective Agents: Antimetabolites and Corticosteroids.
    Van Matre ET; Satyanarayana G; Page 2nd RL; Levi ME; Lindenfeld J; Mueller SW
    Ann Transplant; 2018 Jan; 23():66-74. PubMed ID: 29358572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug interactions of antimicrobial agents in children with cancer].
    Langebrake C; Uhlenbrock S; Ritter J; Groll AH
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S165-74. PubMed ID: 16288362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic investigation of the reduction in antimicrobial activity of ciprofloxacin by metal cations.
    Ma HH; Chiu FC; Li RC
    Pharm Res; 1997 Mar; 14(3):366-70. PubMed ID: 9098883
    [No Abstract]   [Full Text] [Related]  

  • 40. Ciprofloxacin and antacids.
    Fleming LW; Moreland TA; Stewart WK; Scott AC
    Lancet; 1986 Aug; 2(8501):294. PubMed ID: 2874321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.